Nuveen Asset Management, LLC Clene Inc. Transaction History

Nuveen Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.1 - $4.12 $52,747 - $103,486	-25,118 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$3.95 - $7.53 $68,090 - $129,802	-17,238 Reduced 40.7%	25,118 $126,000
Q3 2021 Nov 12, 2021	SELL	$6.83 - $13.58 $85,470 - $169,940	-12,514 Reduced 22.81%	42,356 $341,000
Q2 2021 Aug 16, 2021	BUY	$6.98 - $13.33 $382,992 - $731,417	54,870 New	54,870 $617,000

7.44M

48.1K

160K

Ticker CLNN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 63,502,000
Market Cap $21M
Description
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.